T
AVNS

Tidemark’s Avanos Medical AVNS Stock Holding History

Tidemark’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17
Closed -$238 – 941
2026
Q1 		$238 Hold
17
– – ﹤0.01% 847
2025
Q4 		$191 Hold
17
– – ﹤0.01% 639
2025
Q3 		$197 Hold
17
– – ﹤0.01% 669
2025
Q2 		$208 Sell
17
-11
-39% -$138 ﹤0.01% 689
2025
Q1 		$402 Buy
+28
New +$437 ﹤0.01% 680
2024
Q4 		– Sell
-28
Closed -$673 – 628
2024
Q3 		$673 Sell
28
-3
-10% -$69 ﹤0.01% 587
2024
Q2 		$617 Hold
31
– – ﹤0.01% 582
2024
Q1 		$617 Buy
+31
New +$599 ﹤0.01% 659

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Tidemark's AVNS Position: Q2 2026 in Review

Tidemark sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 17 shares — an estimated $238 sold.

Tidemark first reported a position in AVNS in Q1 2024 and held it in 8 quarters. The position peaked at $673 in Q3 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Tidemark reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Tidemark sold 17 Avanos Medical shares in Q2 2026, an estimated $238.
  • Tidemark first reported a position in Avanos Medical in Q1 2024 and held it in 8 quarters.
  • Tidemark's Avanos Medical position peaked at $673 in Q3 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.